metastatic melanoma

Helping patient’s fight back against deadliest form of skin cancer

/ Geoffrey Lomax Dr. PH / 3 Comments

Caladrius Biosciences has been funded by CIRM to conduct a Phase 3 clinical trial to treat the most severe form of skin cancer: metastatic melanoma. Metastatic melanoma is a disease with no effective treatment, only around 15 percent of people with it survive five years, and every year it claims an estimated 10,000 lives in … Continue reading Helping patient’s fight back against deadliest form of skin cancer

Faster, better, more efficient. Challenging? That too. An update on CIRM 2.0.

/ Kevin McCormack / Leave a comment

Changing direction is never easy. The greater the change the greater the likelihood you’ll have to make adjustments and do some fine-tuning along the way to make sure you get it right. On January 1st of this year we made a big change, launching CIRM 2.0. Our President and CEO Dr. C. Randal Mills called … Continue reading Faster, better, more efficient. Challenging? That too. An update on CIRM 2.0.